Literature DB >> 6426154

Mammosomatotroph hyperplasia associated with acromegaly and hyperprolactinemia in a patient with the McCune-Albright syndrome. A histologic, immunocytologic and ultrastructural study of the surgically-removed adenohypophysis.

K Kovacs, E Horvath, M O Thorner, A D Rogol.   

Abstract

An 11-year-old girl, with the McCune-Albright syndrome, exhibited fibrous dysplasia of several bones, skin pigmentation, precocious puberty, growth hormone hypersecretion, acromegaly and hyper-prolactinemia. Histologic, immunocytologic and ultrastructural investigation of the surgically-removed pituitary showed massive mammosomatotroph hyperplasia. Since no adenoma was found, the abundance of these bihormonal cells, capable of producing both growth hormone and prolactin, was implicated in the causation of growth hormone and prolactin excess. Somatoliberin overproduction and/or somatostatin and dopamine deficiency could not account for the hypophysial abnormality, since changes in secretory rates of these hypothalamic hormones would lead to proliferation of mature somatotrophs and lactotrophs, rather than mammosomatotrophs. In our patient, a congenital hypothalamic malfunction might have been accompanied by hypersecretion of an unidentified releasing factor, resulting in pathologic differentiation of the pituitary and mammosomatotroph hyperplasia. Alternatively, mammosomatotroph hyperplasia may have been due to an inherent genetic or embryonic defect affecting primarily the pituitary. According to this interpretation, the pituitary lesion represented yet another developmental error in the setting of the McCune-Albright syndrome.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6426154     DOI: 10.1007/bf00689340

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  24 in total

1.  Polyostotic fibrous dysplasia (Albright's syndrome); report of a case showing central nervous system changes.

Authors:  G A JERVIS; H SCHEIN
Journal:  AMA Arch Pathol       Date:  1951-06

Review 2.  Pituitary adenomas.

Authors:  K Kovacs; E Horvath; C Ezrin
Journal:  Pathol Annu       Date:  1977

3.  McCune-Albright syndrome associated with a functioning pituitary chromophobe adenoma.

Authors:  S K Joishy; L B Morrow
Journal:  J Pediatr       Date:  1976-07       Impact factor: 4.406

4.  Human prolactin-producing adenomas and bromocriptine: a histological, immunocytochemical, ultrastructural, and morphometric study.

Authors:  G T Tindall; K Kovacs; E Horvath; M O Thorner
Journal:  J Clin Endocrinol Metab       Date:  1982-12       Impact factor: 5.958

5.  Gigantism and hyperprolactinemia in polyostotic fibrous dysplasia (Mc Cune--Albright syndrome).

Authors:  C Polychronakos; G Tsoukas; J R Ducharme; J Letarte; R Collu
Journal:  J Endocrinol Invest       Date:  1982 Sep-Oct       Impact factor: 4.256

6.  Hyperprolactinaemia in a patient with the McCune-Albright Syndrome.

Authors:  D Carr; I K Mathie; A R Manners; C Colman
Journal:  Br J Obstet Gynaecol       Date:  1979-04

7.  The Albright syndrome associated with acromegaly: report of a case and review of the literature.

Authors:  A Lipson; T H Hsu
Journal:  Johns Hopkins Med J       Date:  1981-07

8.  Mammosomatotroph cell adenoma of the human pituitary: a morphologic entity.

Authors:  E Horvath; K Kovacs; D W Killinger; H S Smyth; M H Weiss; C Ezrin
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1983

9.  Acromegaly and hyperprolactinemia in McCune-Albright syndrome. Evidence of hypothalamic dysfunction.

Authors:  K F Chung; J Alaghband-Zadeh; A Guz
Journal:  Am J Dis Child       Date:  1983-02

10.  Rapid regression of pituitary prolactinomas during bromocriptine treatment.

Authors:  M O Thorner; W H Martin; A D Rogol; J L Morris; R L Perryman; B P Conway; S S Howards; M G Wolfman; R M MacLeod
Journal:  J Clin Endocrinol Metab       Date:  1980-09       Impact factor: 5.958

View more
  27 in total

1.  Functional screen analysis reveals miR-26b and miR-128 as central regulators of pituitary somatomammotrophic tumor growth through activation of the PTEN-AKT pathway.

Authors:  T Palumbo; F R Faucz; M Azevedo; P Xekouki; D Iliopoulos; C A Stratakis
Journal:  Oncogene       Date:  2012-05-21       Impact factor: 9.867

2.  Anterior pituitary adenomas: inherited syndromes, novel genes and molecular pathways.

Authors:  Paraskevi Xekouki; Monalisa Azevedo; Constantine A Stratakis
Journal:  Expert Rev Endocrinol Metab       Date:  2010-09-01

3.  Polyostotic fibrous dysplasia with contrasting responses to calcitonin and mithramycin: aetiological and therapeutic implications.

Authors:  A Long; T Loughlin; R P Towers; T J McKenna
Journal:  Ir J Med Sci       Date:  1988-07       Impact factor: 1.568

4.  Pituitary pathology in Carney complex patients.

Authors:  Sotirios G Stergiopoulos; Mones S Abu-Asab; Maria Tsokos; Constantine A Stratakis
Journal:  Pituitary       Date:  2004       Impact factor: 4.107

5.  Somatomammotrophic cells in GH-secreting and PRL-secreting human pituitary adenomas.

Authors:  M Bassetti; M Brina; A Spada; G Giannattasio
Journal:  J Endocrinol Invest       Date:  1989-11       Impact factor: 4.256

6.  A history of pituitary pathology.

Authors:  Sylvia L Asa; Ozgur Mete
Journal:  Endocr Pathol       Date:  2014-03       Impact factor: 3.943

Review 7.  Clinical and molecular genetics of acromegaly: MEN1, Carney complex, McCune-Albright syndrome, familial acromegaly and genetic defects in sporadic tumors.

Authors:  Anelia Horvath; Constantine A Stratakis
Journal:  Rev Endocr Metab Disord       Date:  2008-03       Impact factor: 6.514

8.  Idiopathic prolactin cell hyperplasia of the pituitary mimicking prolactin cell adenoma: a morphological study including immunocytochemistry, electron microscopy, and in situ hybridization.

Authors:  V Jay; K Kovacs; E Horvath; R V Lloyd; H S Smyth
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

9.  Advances in the Diagnosis, Treatment, and Molecular Genetics of Pituitary Adenomas in Childhood.

Authors:  Margaret F Keil; Constantine A Stratakis
Journal:  US Endocrinol       Date:  2009-02-01

10.  Enhanced basal and disorderly growth hormone secretion distinguish acromegalic from normal pulsatile growth hormone release.

Authors:  M L Hartman; S M Pincus; M L Johnson; D H Matthews; L M Faunt; M L Vance; M O Thorner; J D Veldhuis
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.